宫颈癌患者治疗障碍的系统综述
该系统综述检索PubMed、Scopus和CINAHL截至2026年5月,纳入25项美国宫颈癌患者治疗相关结局研究,将决定因素映射至社会生态模型。手术、化疗和近距离放疗是最常评估的结局,少数族裔、高龄、合并症、保险、农村居住和就医距离等患者层面因素及诊所和社区层面因素与治疗结局相关。
要点
- 少数族裔(黑人、西班牙裔、美洲原住民、太平洋岛民)常经历更差的治疗结局。
- 高龄是治疗障碍的常见因素,就医距离与治疗结局关联不一致。
- 在大型医疗机构和学术医学中心之外接受诊疗与更差治疗结局相关。
核心结论
- 美国宫颈癌治疗受患者、诊所和社区多层面决定因素驱动。
- 解决治疗障碍需关注阻碍弱势社区 marginalized 宫颈癌患者治疗的更广泛结构和可改变因素。
- 未来研究应更严格和审慎地测量社区层面和个体层面变量。
研究设计与样本
- 系统综述,方案注册于PROSPERO(CRD42023413020)。
- 检索PubMed、Scopus和CINAHL截至2026年5月发表的文献。
- 纳入25项符合标准的研究,均为美国宫颈癌患者治疗相关结局研究。
主要发现
- 25项研究共识别26项治疗相关结局,手术、化疗和近距离放疗最常被评估。
- 关键患者层面决定因素包括种族/民族、年龄、合并症、保险、农村居住和就医距离。
- 少数族裔(黑人、西班牙裔、美洲原住民、太平洋岛民)常经历更差治疗结局,高龄也是常见障碍。
- 就医距离与治疗结局关联不一致。
- 在大型医疗机构和学术医学中心之外接受诊疗及居住在收入和教育水平较低县与更差治疗结局相关。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Previous reviews have described disparities in the treatment of patients diagnosed with gynecologic cancers; however, these reviews are not systematic in nature, and none have focused specifically on individuals diagnosed with cervical cancer, who disproportionately represent marginalized populations in the US. This systematic review synthesizes evidence on treatment-related outcomes and multilevel determinants of care among US patients with cervical cancer. METHODS: The protocol was registered with PROSPERO (CRD42023413020). We searched PubMed, Scopus, and CINAHL for studies published through May 2026. Eligible studies examined treatment related outcomes among patients diagnosed with cervical cancer in the US. We identified 25 articles that met our inclusion criteria. Treatment-related outcomes were categorized and determinants (i.e., explanatory variables) were mapped on to the socioecological model. RESULTS: Across 25 studies, 26 treatment-related outcomes were identified. Receipt of surgery, chemotherapy, and brachytherapy were the most frequently assessed outcomes. Key patient-level determinants included race/ethnicity, age, comorbidities, insurance, rurality, and distance to care. Minoritized populations, particularly Black, Hispanic, Native American, Pacific Islander, often experienced worse treatment outcomes. Older age was also a frequent barrier to treatment. Distance to care was inconsistently associated with treatment outcomes. Clinic-level determinants, such as care outside of large-volume facilities and academic medical centers, and contextual determinants, such as residing in a county with lower levels of income and education, were associated with worse treatment outcomes. CONCLUSIONS: Cervical cancer treatment in the United States is driven by multilevel determinants at the patient-, clinic-, and community-level. Addressing barriers to treatment requires attention to the broader structural and modifiable factors that hinder treatment for marginalized cervical cancer patients in vulnerable communities. Future studies should more rigorously and thoughtfully measure community-level and individual-level variables.
引用
- Cortez CA, Taffe BD, Ellis C, et al. Barriers to treatment for patients diagnosed with cervical cancer: A systematic review. Gynecol Oncol. 2026. PMID: 43003063. doi:10.1016/j.ygyno.2026.10.031
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。